Stock listing
AZNL Stock Price, News, Filings & Events — Astrazeneca Plc
Selected listing: AZNL · AQUISUK · GBX · GB
This page tracks Astrazeneca Plc's AZNL:AQUISUK listing on AQUISUK in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AZNL:AQUISUK. AZNL:AQUISUK is the stock-level entry point for investors researching Astrazeneca Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.

- Ticker
- AZNL:AQUISUK
- Asset type
- Stock
- Market cap
- $246.29B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- AQUISUK
- Currency
- GBX
Astrazeneca Plc AZNL:AQUISUK stock context
This page tracks Astrazeneca Plc's AZNL:AQUISUK listing on AQUISUK in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AZNL:AQUISUK. AZNL:AQUISUK is the stock-level entry point for investors researching Astrazeneca Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Astrazeneca Plc
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients...
September 13, 2026
TAGRISSO® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase I...
September 13, 2026
Enhertu® Demonstrated a Median Progression-Free Survival of 14.3 Months as First-Line Therapy in Patients with HER2 Mutant Advanced Non-S...
September 13, 2026
AstraZeneca : Update on SERENA-4 Phase III trial of Etcamah in combination with palbociclib in upfront 1st-line advanced ER-positive brea...
September 11, 2026
AstraZeneca : Tozorakimab demonstrated statistically significant and highly clinically meaningful reduction in COPD exacerbations in OBER...
September 8, 2026
Astrazeneca Plc earnings calls
AstraZeneca PLC (AZN) Q2 2026 Earnings Call
July 27, 2026 · Replay with transcript and chapters
AstraZeneca PLC (AZN) Q1 2026 Earnings Call
April 29, 2026 · Replay with transcript and chapters
AstraZeneca PLC (AZN) Q4 2025 Earnings Call
February 10, 2026 · Replay with transcript and chapters
AstraZeneca PLC (AZN) Q3 2025 Earnings Call
November 11, 2025 · Replay with transcript and chapters
AstraZeneca PLC (AZN) Q2 2025 Earnings Call
July 29, 2025 · Replay with transcript and chapters
AstraZeneca PLC (AZN) Q1 2025 Earnings Call
April 29, 2025 · Replay with transcript and chapters
Research Astrazeneca Plc
Astrazeneca Plc investor report
Review AI stock analysis and investor report context for AZNL:AQUISUK.
Astrazeneca Plc company profile
View the public company page for Astrazeneca Plc on 6ix.
Astrazeneca Plc news
Read company news and market updates connected to Astrazeneca Plc.
Astrazeneca Plc investor events
Find investor webinars, events, and replay context for Astrazeneca Plc.
Alternate listings
AZN:LSE
GB · GBX
Alternate listing for Astrazeneca Plc; the primary context on this page is AZNL:AQUISUK.
AZN:NYSE
US · USD
Alternate listing for Astrazeneca Plc; the primary context on this page is AZNL:AQUISUK.
AZN:OMXSTO
SE · SEK
Alternate listing for Astrazeneca Plc; the primary context on this page is AZNL:AQUISUK.
ZEG:GETTEX
DE · EUR
Alternate listing for Astrazeneca Plc; the primary context on this page is AZNL:AQUISUK.
AZN:BCBA
AR · ARS
Alternate listing for Astrazeneca Plc; the primary context on this page is AZNL:AQUISUK.
ZEG:TRADEGATE
DE · EUR
Alternate listing for Astrazeneca Plc; the primary context on this page is AZNL:AQUISUK.
886455:LSX
DE · EUR
Alternate listing for Astrazeneca Plc; the primary context on this page is AZNL:AQUISUK.
ZEG:FWB
DE · EUR
Alternate listing for Astrazeneca Plc; the primary context on this page is AZNL:AQUISUK.
A1ZN34:BMFBOVESPA
BR · BRL
Alternate listing for Astrazeneca Plc; the primary context on this page is AZNL:AQUISUK.
AZN:BOATS
US · USD
Alternate listing for Astrazeneca Plc; the primary context on this page is AZNL:AQUISUK.
886455:LS
DE · EUR
Alternate listing for Astrazeneca Plc; the primary context on this page is AZNL:AQUISUK.
AZNN:BMV
MX · MXN
Alternate listing for Astrazeneca Plc; the primary context on this page is AZNL:AQUISUK.